Want to see GB:OBI full AI Analyst Report?
Ondine Biomedical, Inc. (OBI) Income Statement
Ondine Biomedical, Inc. Income Statement
Last quarter (Q2 2026), Ondine Biomedical, Inc.'s total revenue was $1.23M, an increase of 42.16% from the same quarter last year. In Q2, Ondine Biomedical, Inc.'s net income was $-15.96M. See Ondine Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.65M | $ 2.05M | $ 1.20M | $ 638.00K | $ 2.57M | |
| $ 1.09M | $ 1.32M | $ 703.00K | $ 287.00K | $ 1.25M | |
| $ 31.13M | $ 20.77M | $ 15.51M | $ 19.05M | $ 18.77M | |
| Depreciation and Amortization | $ 591.43K | $ 565.00K | $ 587.00K | $ 493.00K | $ 514.00K |
| $ -29.45M | $ -18.49M | $ -13.79M | $ -18.85M | $ -48.36M | |
| $ -30.04M | $ -19.44M | $ -14.80M | $ -18.76M | $ -17.52M | |
| $ 451.09K | $ 346.00K | $ 393.00K | $ -609.00K | $ -32.56M | |
| $ -29.59M | $ -19.10M | $ -14.41M | $ -19.37M | $ -50.09M | |
| $ -29.59M | $ -19.10M | $ -14.41M | $ -19.37M | $ -50.09M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.06 | $ -0.07 | $ -0.07 | $ -0.10 | $ -0.26 |
| Diluted EPS | $ -0.06 | $ -0.07 | $ -0.07 | $ -0.10 | $ -0.26 |
| Weighted Average Shares Outstanding | 465.08M | 274.60M | 197.11M | 194.59M | 194.59M |
| Weighted Average Shares Outstanding (Diluted) | 465.08M | 274.60M | 197.11M | 194.59M | 194.59M |
Currency in CAD